Artificial intelligence (AI) robots designed by a medical team beat out humans in a race to diagnose brain tumors and predicting brain hematoma expansion, The Next Web reports.
BioMind, the name of the AI solution, was developed by the Artificial Intelligence Research Centre for Neurological Disorders at Beijing Tiantan Hospital. According to The Next Web, BioMind “was correct 87 percent of the time, compared to 66 percent by the medical professionals” when diagnosing brain tumors, and only took 15 minutes to diagnose those 225 cases, while doctors needed 30.
The AI solution was also correct in 83 percent of cases in predicting brain hematoma expansion, while doctors managed only 63 percent.
In order to make BioMind so powerful, researchers “trained the AI by feeding it thousands upon thousands of images from Beijing Tiantan Hospital’s archives” over the course of ten years, which “has made it as good at diagnosing neurological diseases as senior doctors, as it has a 90 percent accuracy rate.”
In a similar report by XinhuaNet, doctors working with BioMind consider the AI solution as a partner, or “friend” in their field, and think that it will take human capabilities to the next level while treating patients. “AI will not only reduce the workload but also push doctors to keep learning and improve their skills,” Lin Yi, a doctor at Tiantan Hospital, told XinhuaNet.
Executive Vice President of the hospital, Wang Yongjun, told XinhuaNet that he “didn’t care” if either BioMind or the doctors won during the competition; “the contest was never intended to pit humans against technology.”
“I hope through this competition, doctors can experience the power of artificial intelligence,”
he said. “This is especially so for some doctors who are skeptical about artificial intelligence. I hope they can further understand AI and eliminate their fears toward it.”